These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2148170)

  • 1. Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells.
    Bruso CE; Shewach DS; Lawrence TS
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1411-7. PubMed ID: 2148170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
    Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
    Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of fluorodeoxyuridine on sublethal damage repair in human colon cancer cells.
    Heimburger DK; Shewach DS; Lawrence TS
    Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):983-7. PubMed ID: 1833363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization.
    McGinn CJ; Miller EM; Lindstrom MJ; Kunugi KA; Johnston PG; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):851-9. PubMed ID: 7960987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of leucovorin and dipyridamole on fluoropyrimidine-induced radiosensitization.
    Lawrence TS; Heimburger DK; Shewach DS
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):377-81. PubMed ID: 1991704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression.
    Lawrence TS; Davis MA; Tang HY; Maybaum J
    Int J Radiat Biol; 1996 Sep; 70(3):273-80. PubMed ID: 8800198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence of fluorodeoxyuridine-mediated radiosensitization on S phase progression.
    Davis MA; Tang HY; Maybaum J; Lawrence TS
    Int J Radiat Biol; 1995 May; 67(5):509-17. PubMed ID: 7775826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization of cultured human colon adenocarcinoma cells by 5-fluorouracil: effects on cell survival, DNA repair, and cell recovery.
    Hughes LL; Luengas J; Rich TA; Murray D
    Int J Radiat Oncol Biol Phys; 1992; 23(5):983-91. PubMed ID: 1639656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of dependence of 5-fluorodeoxyuridine-mediated radiosensitization on cytotoxicity.
    Lawrence TS; Davis MA; Chang EY; Canman CE; Maybaum J; Radany EH
    Radiat Res; 1995 Sep; 143(3):281-5. PubMed ID: 7652165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
    Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
    Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short hairpin RNA suppression of thymidylate synthase produces DNA mismatches and results in excellent radiosensitization.
    Flanagan SA; Cooper KS; Mannava S; Nikiforov MA; Shewach DS
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e613-20. PubMed ID: 22867891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Checkpoint signaling, base excision repair, and PARP promote survival of colon cancer cells treated with 5-fluorodeoxyuridine but not 5-fluorouracil.
    Geng L; Huehls AM; Wagner JM; Huntoon CJ; Karnitz LM
    PLoS One; 2011; 6(12):e28862. PubMed ID: 22194930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MLH1 deficiency enhances radiosensitization with 5-fluorodeoxyuridine by increasing DNA mismatches.
    Flanagan SA; Krokosky CM; Mannava S; Nikiforov MA; Shewach DS
    Mol Pharmacol; 2008 Sep; 74(3):863-71. PubMed ID: 18535288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and molecular effects of UCN-01 in combination with 5-fluorodeoxyuridine in A431 human epidermoid cancer cells.
    Grem JL; Danenberg KD; Kao V; Danenberg PV; Nguyen D
    Anticancer Drugs; 2002 Mar; 13(3):259-70. PubMed ID: 11984070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells.
    Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
    Radiat Res; 1990 Aug; 123(2):192-8. PubMed ID: 2389005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
    Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
    Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death.
    Yoshioka A; Tanaka S; Hiraoka O; Koyama Y; Hirota Y; Ayusawa D; Seno T; Garrett C; Wataya Y
    J Biol Chem; 1987 Jun; 262(17):8235-41. PubMed ID: 2954951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of activation of wild-type p53 function on fluoropyrimidine-mediated radiosensitization.
    Naida JD; Davis MA; Lawrence TS
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):675-80. PubMed ID: 9635719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations in patterns of DNA damage induced in human colorectal tumor cells by 5-fluorodeoxyuridine: implications for mechanisms of resistance and cytotoxicity.
    Canman CE; Tang HY; Normolle DP; Lawrence TS; Maybaum J
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10474-8. PubMed ID: 1438236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV16-E7 expression causes fluorodeoxyuridine-mediated radiosensitization in SW620 human colon cancer cells.
    Axelson MD; Davis MA; Ethier SP; Lawrence TS
    Neoplasia; 1999 Jun; 1(2):177-82. PubMed ID: 10933053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.